Notwithstanding the ongoing coronavirus disease-2019 (Covid-19) pandemic, information
on its clinical presentation and prognosis in recipients of a kidney transplant remain scanty. …

There are no studies which have compared the risk of severe COVID‐19 and related mortality
between transplant recipients and nontransplant patients. We enrolled two groups of …

1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19
vaccine. N Engl J Med. 2020; 383: 2603-2615. 2. Baden LR, El Sahly HM, Essink B, et al. …

End stage kidney disease increase the risk of COVID-19 related death but how the kidney
replacement strategy should be adapted during the pandemic is unknown. Chronic …

Results We identified primary thrombotic microangiopathies in 33 of 564 patients (6%;
thrombotic thrombocytopenic purpura: 18 of 564 [3%]; atypical hemolytic and uremic syndrome: …

Background Atypical hemolytic uremic syndrome (HUS) is associated with high recurrence
rates after kidney transplant, with devastating outcomes. In late 2011, experts in France …

The aim of this study (ClinicalTrials.gov, NCT01744470) was to determine the efficacy and
safety of two different doses of extended-release tacrolimus (TacER) in kidney transplant …

Results Major bleeding occurred in 2765 of 52,138 (5%) patients (blood transfusions: 5%;
angiographic intervention: 0.4%; and nephrectomy: 0.1%). Nineteen diagnoses were …

Cytomegalovirus (CMV) infection is a significant complication after kidney transplantation.
We examined the ability of RG7667, a combination of two monoclonal antibodies, to prevent …

Background PKD2-related autosomal dominant polycystic kidney disease (ADPKD) is
widely acknowledged to be of milder severity than PKD1-related disease, but population-based …